Last year in the UK over 60,000 cancer patients enrolled on clinical trials aimed at improving cancer treatments and making them available to all.
A study to learn more about the causes of myeloproliferative disorders
This study is to see if there is a link between proteins called tyrosine kinases and the abnormal production of blood cells.
If doctors understood more about how MPDs develop, they may be able to improve treatment for this group of conditions. Scientists think that MPDs develop because proteins called
The aim of this study is to try to explain how MPDs develop. And to use this information to develop new treatments in the future. You will not have any direct benefit from taking part in this study, and it is unlikely to change your treatment plan in any way. But the results of the study will be used to help people in the future.
Who can enter
This study hopes to recruit as many people as possible with a
If you are due to have a
You will give your study blood sample when you have your next routine blood test. And your bone marrow sample when you are due for your bone marrow test. So you will not need to make any extra hospital visits for this study.
As you are having one or both of these tests anyway, you will not have any extra side effects from taking part in this study.
You may have a small bruise where you had your blood test. If you have a bone marrow test, your hip may ache for a couple of days. You may need to take some mild painkillers for this.
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor N.C.P. Cross
Dr A.S Duncombe
Experimental Cancer Medicine Centre (ECMC)
University Hospital Southampton NHS Foundation Trust